Related Experiment Video

Updated: Jun 23, 2026

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

Clinical management of HIV infection in children

Siobhan Crowley1, Adeodata Kekitiinwa, Paula Vaz

  • 1aPaediatric and Family HIV Care, Department of HIV/AIDS, World Heath Organization, Geneva, Switzerland bBaylor College of Medicine Children's Foundation-Uganda, Mulago Hospital PIDC, Kampala, Uganda cPediatric Day Hospital Director, Maputo Central Hospital, Maputo, Mozambique.

Current Opinion in HIV and AIDS
|April 18, 2009
PubMed

Insights

Advances in HIV care for children include improved antiretroviral treatment guidelines and co-trimoxazole prophylaxis. Research is needed for optimal feeding, diagnostics, and new drugs to manage long-term HIV in children.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Clinical care for HIV-infected children faces technical and operational challenges.
  • Antiretroviral treatment guidelines and co-trimoxazole prophylaxis are increasingly available globally.
  • Implementation of HIV care policies often lags behind recommendations.

Purpose of the Study:

  • To review recent advancements in the clinical management of children with HIV.
  • To highlight progress and persistent challenges in pediatric HIV care.
  • To identify areas for future research and development.

Main Methods:

  • Literature review of recent clinical studies and guidelines.
  • Analysis of data on HIV diagnosis, treatment, and outcomes in children.
  • Synthesis of information on infant feeding practices and HIV transmission risks.

Main Results:

  • Antiretroviral treatment efficacy in children is well-established, with earlier initiation recommended, especially for infants.
  • HIV-free survival rates are comparable between replacement-fed and breastfed infants.
  • Children on antiretroviral therapy are surviving into adulthood, presenting new challenges in managing adolescents and highly treatment-experienced individuals.

Conclusions:

  • Future HIV care requires novel antiretroviral drugs and classes.
  • Urgent research is needed for optimal nutritional interventions and interpretation of immunological/virological markers.
  • Development of diagnostic tools for resource-limited settings is crucial.
Abstract

More Related Videos

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...